14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Wed, 24 Apr 2024

Trading levels for CERS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.84 9.52 %
R2 1.79 6.57 %
R1 1.76 4.74 %
Current price: 1.68
Support S1 1.66 -1.17 %
S2 1.63 -3.00 %
S3 1.58 -5.95 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.04 21.43 %
R2 1.97 17.26 %
R1 1.75 4.17 %
Current price 1.68
Support S1 1.64 -2.38%
S2 0 .
S3 0 .

CERS Predictions History

9 months ago
JS predicted that CERS for 2023-07-19 is going $2.81 (-3.77%)

9 months ago
PredictionBot.Kathy predicted that CERS for 2023-07-19 is going $2.71 (-7.18%)

9 months ago
PredictionBot.Warren predicted that CERS for 2023-07-19 is going $2.73 (-6.41%)

3 years ago
cbrennem.228522 predicted that CERS for 2021-04-20 is going

Rank:

3 years ago
JS predicted that CERS for 2021-03-12 is going $6.42 (0.47%)

3 years ago
SHAMOO predicted that CERS for 2021-03-12 is going

3 years ago
JS predicted that CERS for 2020-12-23 is going $8.25 (0.98%)

3 years ago
Jessie Qu predicted that CERS for 2020-12-23 is going

Rank:

3 years ago
JS predicted that CERS for 2020-08-25 is going $6.74 (6.73%)

3 years ago
2poJeff predicted that CERS for 2020-08-25 is going $7.06 (3.37%)

Click to get the best stock tips daily for free!

About Cerus Corporation

Cerus Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed t... CERS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT